Dena Grayson

American Medical Doctor And Biochemist

Dena Grayson was born in Melbourne, Florida, United States on January 5th, 1971 and is the American Medical Doctor And Biochemist. At the age of 53, Dena Grayson biography, profession, age, height, weight, eye color, hair color, build, measurements, education, career, dating/affair, family, news updates, and networth are available.

  Report
Date of Birth
January 5, 1971
Nationality
United States
Place of Birth
Melbourne, Florida, United States
Age
53 years old
Zodiac Sign
Capricorn
Profession
Lobbyist, Physician
Dena Grayson Height, Weight, Eye Color and Hair Color

At 53 years old, Dena Grayson physical status not available right now. We will update Dena Grayson's height, weight, eye color, hair color, build, and measurements.

Height
Not Available
Weight
Not Available
Hair Color
Not Available
Eye Color
Not Available
Build
Not Available
Measurements
Not Available
Dena Grayson Religion, Education, and Hobbies
Religion
Not Available
Hobbies
Not Available
Education
University of Florida (BSc), Washington University (MSc, MD, PhD)
Dena Grayson Spouse(s), Children, Affair, Parents, and Family
Spouse(s)
Alan Grayson (2016–present)
Children
Not Available
Dating / Affair
Not Available
Parents
Not Available
Dena Grayson Career

Grayson has a (M.D.) degree. In the early 2000s, she shifted her focus to medical research as a way of treating multiple patients by finding cures. She worked as a biotechnology consultant at MEDACorp from 2002-2003. From 2003 to 2008, Grayson served as an Associate Director of Licensing and Director of Medical Sciences at Amgen, and worked on developing treatments for cancers, asthma, anemia, hypercholesterolemia, heart failure, and pain. While at Amgen, she was selected as a Henry Crown Fellow at the Aspen Institute in 2006. Grayson then served as Vice President of Translational Sciences at 3-V Biosciences from 2008 to 2010, where she oversaw the development of broad-spectrum antiviral drugs active against deadly viruses. She served as the Vice President of Translational Sciences for AlloCure from 2011 to 2014, where she led research on a mesenchymal stem cell therapy for acute kidney injury. In 2010, Grayson founded MedExpert Consulting, a biotechnology consulting company, where she helped research and develop BCX4430, a broad-spectrum antiviral drug that is active against Ebola, Marburg, Yellow Fever, Zika, and other deadly viral diseases. Grayson briefly lobbied for BioCryst Pharmaceuticals for 3 months in 2013 and for 1 month in 2014 to fund research of a treatment for Ebola and other deadly viruses. In 2014, she was co-author of an article published in Nature on the efficacy of BCX4430 against Marburg virus and of a paper on the activity of BCX4430 against Yellow Fever.

In 2016, she ran unsuccessfully for the Democratic nomination for the United States House of Representatives for Florida's 9th congressional district. Since 2016, Grayson is a regular political commentator on Twitter, and asked onto media such as Fox News to speak on issues such as the Democrats proposal to reform elections. Grayson attended the Michael Cohen hearing in February 2019.

Source